Hyperrab 300 unit/ML vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0A5H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,789
Award facts
- Contract value 100% obligated
- $19,789.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,789.20 to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 27, 2026, for the supply of HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 18, 2026, and will be performed at the company's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitive procurements through firm fixed-price delivery orders, ranging from small transactions to substantial orders exceeding $45,000. This award reflects the company's established capability to meet federal medical supply requirements and its continued support of the Defense Logistics Agency's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F0A5H?
SPE2DR26F0A5H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F0A5H worth?
The government has obligated $19,789 on SPE2DR26F0A5H.
Is contract SPE2DR26F0A5H an order under another contract?
Yes. SPE2DR26F0A5H is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A5H competed?
The extent of competition for SPE2DR26F0A5H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award